International symposium on standardization of the immunopharmacology of natural and synthetic immunomodulators : proceedings of a symposium organized by the International Association of Biological Standardization held at the Palais des Congrès, Annecy, France 15-17 May 1991
Author(s)
Bibliographic Information
International symposium on standardization of the immunopharmacology of natural and synthetic immunomodulators : proceedings of a symposium organized by the International Association of Biological Standardization held at the Palais des Congrès, Annecy, France 15-17 May 1991
(Developments in biological standardization, 77)
Karger, c1992
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
Immunomodulators - compounds capable of modulating the immune response - are today used primarily in cancer immunotherapy and the prevention or treatment of recurrent respiratory tract infections. They belong to a pharmacological class composed of drugs that are very heterogeneous in terms of both their origins and their effects on the immune system. Standardization of such a heterogeneous group of agents raises considerable difficulties at each stage from the screening of a potentially active compound, over its development, production and control, to preclinical evaluation and clinical trials. This volume summarizes a body of experience and presents essential guidelines for the in vitro, preclinical and clinical evaluation of immunomodulators. It documents the results of active collaboration among immunologists, clinicians, toxicologists, statisticians, and scientists from industry covering all major aspects of the standardization of immunomodulators.
by "Nielsen BookData"